Macquarie Group
NVCR icon

Macquarie Group’s NovoCure NVCR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-13,250
Closed -$214K 1659
2023
Q3
$214K Sell
13,250
-1,638
-11% -$26.5K ﹤0.01% 1519
2023
Q2
$618K Sell
14,888
-7,406
-33% -$307K ﹤0.01% 1429
2023
Q1
$1.34M Sell
22,294
-57,955
-72% -$3.48M ﹤0.01% 1289
2022
Q4
$5.89M Buy
80,249
+9,386
+13% +$688K 0.01% 952
2022
Q3
$5.38M Buy
70,863
+22,142
+45% +$1.68M 0.01% 973
2022
Q2
$3.39M Sell
48,721
-40,399
-45% -$2.81M ﹤0.01% 1139
2022
Q1
$7.38K Sell
89,120
-314,295
-78% -$26K 0.01% 1011
2021
Q4
$30.3M Sell
403,415
-267,112
-40% -$20.1M 0.03% 643
2021
Q3
$77.9M Sell
670,527
-241,663
-26% -$28.1M 0.07% 382
2021
Q2
$202M Buy
912,190
+208,856
+30% +$46.3M 0.17% 137
2021
Q1
$93M Sell
703,334
-488,162
-41% -$64.5M 0.13% 175
2020
Q4
$206M Sell
1,191,496
-323,259
-21% -$55.9M 0.3% 61
2020
Q3
$169M Buy
1,514,755
+573,853
+61% +$63.9M 0.29% 62
2020
Q2
$55.8M Sell
940,902
-365,543
-28% -$21.7M 0.1% 231
2020
Q1
$88M Buy
1,306,445
+321,487
+33% +$21.6M 0.18% 100
2019
Q4
$83M Buy
984,958
+11,279
+1% +$950K 0.12% 158
2019
Q3
$72.8M Sell
973,679
-335,541
-26% -$25.1M 0.12% 162
2019
Q2
$82.8M Buy
1,309,220
+146,726
+13% +$9.28M 0.14% 138
2019
Q1
$56M Sell
1,162,494
-62,981
-5% -$3.03M 0.1% 222
2018
Q4
$41M Buy
1,225,475
+121,358
+11% +$4.06M 0.08% 265
2018
Q3
$57.9M Buy
1,104,117
+519,988
+89% +$27.2M 0.09% 224
2018
Q2
$18.3M Buy
584,129
+506,526
+653% +$15.9M 0.03% 499
2018
Q1
$1.69M Buy
77,603
+7,537
+11% +$164K ﹤0.01% 1035
2017
Q4
$1.42M Buy
70,066
+19,606
+39% +$396K ﹤0.01% 1131
2017
Q3
$1M Sell
50,460
-16,882
-25% -$335K ﹤0.01% 1210
2017
Q2
$1.17M Sell
67,342
-28,035
-29% -$485K ﹤0.01% 1122
2017
Q1
$773K Sell
95,377
-2,710
-3% -$22K ﹤0.01% 1237
2016
Q4
$770K Buy
98,087
+15,218
+18% +$119K ﹤0.01% 1232
2016
Q3
$708K Sell
82,869
-68,425
-45% -$585K ﹤0.01% 1231
2016
Q2
$1.77M Buy
+151,294
New +$1.77M ﹤0.01% 1171